Seres Therapeutics, Inc. (MCRB) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2013: $174.0K2014: $1.00M2015: $4.36M2016: $21.49M2017: $4.68M2018: $1.94M2019: $1.00M2020: $591.0K2021: $9.57M2022: $9.82M2023: $7.97M2024: $380.0K2025: $252.0K$252.0K
2013Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$252.0K-33.7%
2024$380.0K-95.2%
2023$7.97M-18.8%
2022$9.82M+2.7%
2021$9.57M+1518.6%
2020$591.0K-41.0%
2019$1.00M-48.3%
2018$1.94M-58.6%
2017$4.68M-78.2%
2016$21.49M+392.7%
2015$4.36M+335.8%
2014$1.00M+475.3%
2013$174.0K